Zhaoguo Wang

Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial

Guizhen Wu, Jin Zhang, W. Lei, 2022, Signal Transduction and Targeted Therapy.

Research on the Construction of a Natural Hazard Emergency Relief Alliance Based on the Public Participation Degree

P. Tadikamalla, Jing Zhang, Ying-xin Chen, 2020, Sustainability.

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial

Guizhen Wu, Jin Zhang, W. Lei, 2022, Nature Communications.

Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial

Guizhen Wu, Zhixin Ma, Shi Chen, 2023, Signal Transduction and Targeted Therapy.